Product Code: ETC8279626 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Gastric Cancer Treatment Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Gastric Cancer Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Gastric Cancer Treatment Market - Industry Life Cycle |
3.4 Mexico Gastric Cancer Treatment Market - Porter's Five Forces |
3.5 Mexico Gastric Cancer Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Mexico Gastric Cancer Treatment Market Revenues & Volume Share, By Stage, 2021 & 2031F |
3.7 Mexico Gastric Cancer Treatment Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 Mexico Gastric Cancer Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Mexico Gastric Cancer Treatment Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.10 Mexico Gastric Cancer Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Mexico Gastric Cancer Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of gastric cancer in Mexico |
4.2.2 Advancements in treatment options and technologies |
4.2.3 Growing awareness about early detection and screening programs |
4.3 Market Restraints |
4.3.1 High costs associated with advanced treatment options |
4.3.2 Limited access to specialized healthcare facilities in certain regions of Mexico |
5 Mexico Gastric Cancer Treatment Market Trends |
6 Mexico Gastric Cancer Treatment Market, By Types |
6.1 Mexico Gastric Cancer Treatment Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Mexico Gastric Cancer Treatment Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Mexico Gastric Cancer Treatment Market Revenues & Volume, By Adenocarcinoma, 2021- 2031F |
6.1.4 Mexico Gastric Cancer Treatment Market Revenues & Volume, By Lymphoma, 2021- 2031F |
6.1.5 Mexico Gastric Cancer Treatment Market Revenues & Volume, By Gastrointestinal Stromal Tumor, 2021- 2031F |
6.1.6 Mexico Gastric Cancer Treatment Market Revenues & Volume, By Carcinoid Tumor, 2021- 2031F |
6.1.7 Mexico Gastric Cancer Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Mexico Gastric Cancer Treatment Market, By Stage |
6.2.1 Overview and Analysis |
6.2.2 Mexico Gastric Cancer Treatment Market Revenues & Volume, By Stage I, 2021- 2031F |
6.2.3 Mexico Gastric Cancer Treatment Market Revenues & Volume, By Stage II, 2021- 2031F |
6.2.4 Mexico Gastric Cancer Treatment Market Revenues & Volume, By Stage III, 2021- 2031F |
6.2.5 Mexico Gastric Cancer Treatment Market Revenues & Volume, By Stage IV, 2021- 2031F |
6.3 Mexico Gastric Cancer Treatment Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 Mexico Gastric Cancer Treatment Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.3.3 Mexico Gastric Cancer Treatment Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.3.4 Mexico Gastric Cancer Treatment Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.3.5 Mexico Gastric Cancer Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Mexico Gastric Cancer Treatment Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Mexico Gastric Cancer Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.4.3 Mexico Gastric Cancer Treatment Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.5 Mexico Gastric Cancer Treatment Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Mexico Gastric Cancer Treatment Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.5.3 Mexico Gastric Cancer Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.4 Mexico Gastric Cancer Treatment Market Revenues & Volume, By Research and Academic, 2021- 2031F |
6.5.5 Mexico Gastric Cancer Treatment Market Revenues & Volume, By Institutes, 2021- 2031F |
6.5.6 Mexico Gastric Cancer Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Mexico Gastric Cancer Treatment Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Mexico Gastric Cancer Treatment Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.3 Mexico Gastric Cancer Treatment Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.4 Mexico Gastric Cancer Treatment Market Revenues & Volume, By Others, 2021- 2031F |
7 Mexico Gastric Cancer Treatment Market Import-Export Trade Statistics |
7.1 Mexico Gastric Cancer Treatment Market Export to Major Countries |
7.2 Mexico Gastric Cancer Treatment Market Imports from Major Countries |
8 Mexico Gastric Cancer Treatment Market Key Performance Indicators |
8.1 Patient survival rates post-treatment |
8.2 Adoption rates of innovative treatment modalities |
8.3 Participation rates in gastric cancer screening programs |
8.4 Number of healthcare facilities offering comprehensive gastric cancer treatment |
8.5 Patient satisfaction with the quality of care received |
9 Mexico Gastric Cancer Treatment Market - Opportunity Assessment |
9.1 Mexico Gastric Cancer Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Mexico Gastric Cancer Treatment Market Opportunity Assessment, By Stage, 2021 & 2031F |
9.3 Mexico Gastric Cancer Treatment Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 Mexico Gastric Cancer Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Mexico Gastric Cancer Treatment Market Opportunity Assessment, By End User, 2021 & 2031F |
9.6 Mexico Gastric Cancer Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Mexico Gastric Cancer Treatment Market - Competitive Landscape |
10.1 Mexico Gastric Cancer Treatment Market Revenue Share, By Companies, 2024 |
10.2 Mexico Gastric Cancer Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |